期刊文献+

参麦注射液联合西药治疗急性脑梗死的疗效及不良反应分析 被引量:1

Analysis the Untoward and Curative Effect of Shenmai Injection Combine With Western Medicine in Treatment of Acute Cerebral Infarction
下载PDF
导出
摘要 目的探讨参麦注射液联合西药治疗急性脑梗死的临床效果。方法采用随机数字法将在我院治疗50例的急性脑梗死患者分为对照组和观察组。对照组给予传统西药阿司匹林和阿托伐他汀治疗,观察组给予参麦注射液联合阿司匹林和阿托伐他汀治疗。观察两组患者治疗效果,并对比不良反应发生率。结果观察组的总有效率高于对照组(P<0.05);两组不良反应发生率比较差异无统计学意义(P>0.05)。结论参麦注射液联合西药治疗急性脑梗死比单一使用传统西药的治疗效果更加显著。 Objective To expolre the clinical effect of Shenmai injection combined with western medicine in the treatment of cerebral infarction. Methods According to the random digital table method were divied into 50 patients with acute cerebral infarction the control group and the experimental group in our hospital. The control group were treated with conventional western medicine aspirin and atorvastatin, and the experimental group were treated with shenmai injection combined with aspirin and atorvastatin.The treatment effects of the two groups were observed,and the rates of adverse reactions were compared. Results The total effective rate of the experimental group was higher than the control group(P〈0.05), and the difference of the rates of adverse reactions between the two groups was not statistically significant(P〉0.05). Conclusion The treatment of acute cerebral infarction with shenmai injection combined with western medicine is more significant than that of single traditional western medicine,which is worthy of promotion and the clinical use.
出处 《中国继续医学教育》 2016年第4期201-202,共2页 China Continuing Medical Education
关键词 参麦注射液 阿司匹林 阿托伐他汀 急性脑梗死 Shenmai injection Aspirin Atorvastatin Acute cerebral infarction
  • 相关文献

参考文献8

二级参考文献33

  • 1陈海华,黄胜强.阿托伐他汀治疗急性心肌梗死患者的效果及对血脂水平的影响[J].中国老年学杂志,2014,34(7):1926-1927. 被引量:16
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33004
  • 3脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15736
  • 4周良学,游潮,罗林丽,蔡博文.重型闭合性颅脑损伤继发脑梗塞的机制和治疗[J].中华神经外科疾病研究杂志,2006,5(5):403-406. 被引量:12
  • 5刘萍,崔桂萍,陆卉.DJ-1对脑梗死患者早期诊断价值的研究[J].中国老年心血管病杂志,2011,13(9):814-816.
  • 6陈旭,鲁晓华,马晓波,等.183例急性脑梗死与脑血管病危险因素关系分析[J].中西医结合心血管病杂志,2012,10(3):296-298.
  • 7Grundy SM,Cleeman JI,Merz CN,et al.Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines[J].Circulation,2004,110(2):227-239.
  • 8Ridker PM,Hennekens CH,Buring JE,et al.C-reactive protein and other markers of inflammation in the prediction of cardiovascu lar disease in women[J].N Engl J Med,2000,342(12):836-843.
  • 9Hayashidani S,Tsutsui H,Shiomi T,et al.Fluvastat in,a3-hydroxy-3-m ethylglutary lcoenzyme A reductase inhibitor,attenuates left ventricu larrem odeling and failure after experimental myocardial infarctin[J].Circulation,2002,105(7):868.
  • 10Bian Z,Liu B,Moher D,et al.Consolidated standards of reporting trials(CONSORT)for traditional Chinese medicine:current situation and future development[J].Front Med,2011,5(2):171.

共引文献42955

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部